Mass spectrometry, and especially electrospray ionization, is now an efficient tool to study noncovalent interactions between proteins and inhibitors. It is used here to study the interaction of some weak inhibitors with the NCoA-1/STAT6 protein with KD values in the μM range. High signal intensities corresponding to some nonspecific electrostatic interactions between NCoA-1 and the oppositely charged inhibitors were observed by nanoelectrospray mass spectrometry, due to the use of high ligand concentrations. Diverse strategies have already been developed to deal with nonspecific interactions, such as controlled dissociation in the gas phase, mathematical modeling, or the use of a reference protein to monitor the appearance of nonspecific complexes. We demonstrate here that this last methodology, validated only in the case of neutral sugar-protein interactions, i.e., where dipole-dipole interactions are crucial, is not relevant in the case of strong electrostatic interactions. Thus, we developed a novel strategy based on half-maximal inhibitory concentration (IC50) measurements in a competitive assay with readout by nanoelectrospray mass spectrometry. IC50 values determined by MS were finally converted into dissociation constants that showed very good agreement with values determined in the liquid phase using a fluorescence polarization assay.
ABSTRACT:
Mass spectrometry, and especially electrospray ionization, is now an efficient tool to study noncovalent interactions between proteins and inhibitors. It is used here to study the interaction of some weak inhibitors with the NCoA-1/STAT6 protein with K D values in the μM range. High signal intensities corresponding to some nonspecific electrostatic interactions between NCoA-1 and the oppositely charged inhibitors were observed by nanoelectrospray mass spectrometry, due to the use of high ligand concentrations. Diverse strategies have already been developed to deal with nonspecific interactions, such as controlled dissociation in the gas phase, mathematical modeling, or the use of a reference protein to monitor the appearance of nonspecific complexes. We demonstrate here that this last methodology, validated only in the case of neutral sugar/protein interactions, i.e.
where dipole-dipole interactions are crucial, is not relevant in the case of strong electrostatic interactions. Thus, we developed a novel strategy based on half-maximal inhibitory concentration (IC 50 ) measurements in a competitive assay with readout by nanoelectrospray mass spectrometry.
IC 50 values determined by MS were finally converted into dissociation constants that showed very good agreement with values determined in the liquid phase using a fluorescence polarization assay.
Introduction:
There is a strong interest in the study of non-covalent complexes between biomolecules, which are playing key roles in life. Numerous solution-phase analytical techniques were developed in order to determine the specificity and the strength of these types of interactions [1] . Mass spectrometry (MS), and especially electrospray ionization (ESI) [2] , has become an efficient tool to study specific noncovalent complexes between various species (protein-protein, protein-small molecules, protein-DNA, DNA-DNA …) [38] . In fact, ESI is a very soft ionization technique, i.e. non-covalent complexes can be transferred intact from solution into the gas phase. Quantitative information such as stoichiometry, binding constants, or reaction kinetics, can be obtained by ESI-MS and values are often in good agreement with data coming from well-established solution phase techniques.
Nevertheless, the study of non-covalent [protein : ligand] complexes requires careful control of experimental parameters. Buffer, pH, pressure and voltages applied to the different stages of the mass spectrometer have great influence on spectral characteristics and on the information gained.
Moreover, electrochemical reactions and desolvation/ionization mechanisms involved in ESI can also complicate the analysis, thus giving rise to the so-called nonspecific interactions (i.e. interactions with nonspecific binding sites) which alter the solution phase stoichiometry. To study weak complexes with dissociation constants (K D ) in the μM range or higher in solution, high ligand concentrations are employed leading to an increase of the nonspecific gas-phase interactions and to underestimate K D values, which could not reflect the solution-phase equilibria anymore [5, [9] [10] [11] [12] [13] [14] [15] [16] .
Three strategies have been developed to determine affinities of weak [protein : ligand] complexes by ESI-MS, even when nonspecific gas-phase interactions unsettle the analysis.
1. One possibility is to disrupt the nonspecific gas-phase interactions between ligand and protein, by using blackbody infrared radiation dissociation (BIRD) [12] . Nonetheless it was shown that, in some cases, nonspecific interactions can be even stronger than the specific interactions, leading to the destruction of the complex of interest [5] .
Daubenfeld et al.
have shown that specific ligand binding is modeled as a binomial distribution, while complexes resulting from nonspecific gas-phase interactions follow a statistical Poisson distribution [15] . As a consequence, the contributions of specific and nonspecific binding on the mass peak distributions could be modeled from the dependence on ligand concentration. This method has been successfully used to determine the affinity range of ADP and ATP binding with creatine kinase. However, since many numerical parameters of the model have to be adjusted, high quality spectra are required and initial knowledge of the specific interactions is required.
3. Klassen et al. [16] reported a third strategy: a reference protein which is known to not specifically bind with the ligand in solution phase is added to the sample mixture consisting of the ligand and the target protein. Detection of noncovalent complexes between the ligand and the reference protein by nanoESI-MS results only from gas phase interactions. Peak intensities and their distribution could be used to model gas phase interactions between the ligand and the target protein.
The principal assumption is that the distribution of ligand molecules binding nonspecifically to proteins during the nanoESI process is determined by the number of free ligand molecules in the shrinking nanodroplets: interactions should proceed independently from the size and the structure of the protein or the protein complex.
Considering the key role of MS in the drug discovery process, we focused on the development of new ESI assays which could be of value to measure the affinity of noncovalent [protein : peptide] complexes, even when partial nonspecific interactions are exhibited in the gas phase. As example of the methodology, we explore the binding of some cyclopeptides with PAS-B domain of the coactivator protein NCoA-1 (also called steroid receptor coactivator-1, SRC-1). NCoA-1 is one of the essential proteins involved in the Interleukin-4/Interleukin-13 (IL4/IL13) signaling cascade which controls the activation of genes implicated in immune and anti-inflammatory responses [17, 18] One of these components is the coactivator protein NCoA-1 [19] . It has been proposed that blocking the binding of STAT6 and NCoA-1 are potentially of therapeutic interest for the treatment of allergic reactions, including asthma and atopic diseases [20, 21] . In the following report, we propose to use a reference peptide with a known K D value for the NCoA-1 PAS-B domain.
Displacement of the reference peptide from the protein by an inhibitor leads a decrease in the peak intensity of the reference protein/peptide complex. As internal standard, a second protein, i.e. myoglobin, has been chosen to bind with neither the reference peptide nor the inhibitor in solution as well as in the gas phase. After normalization, data are fitted to a sigmoid equation to determine the IC 50 values from the dependence on inhibitor concentration. Thereafter K D values of the competitive inhibitors are extrapolated using a general Cheng-Prusoff equation.
Material and methods: Chemicals:
Commercial reagents were used without further purification. Myoglobin, lysozyme, lactalbumin, ammonium bicarbonate, methanol and acetic acid were purchased from Sigma (Sigma-Aldrich Chemie GmbH, Buchs, Switzerland).
Peptide synthesis:
Peptides (1), (2), and (6) and inhibitors A, B and C (Table 1) were synthesized by solid phase methods using standard Fmoc chemistry on an Applied Biosystems 433A peptide synthesizer. The backbone-cyclic peptides were assembled on 2-chlorotrityl chloride resin (Novabiochem). The synthesis of peptide 1 is described here as a typical procedure. + ion.
Stock solutions: each peptide was dissolved in an ammonium bicarbonate (50 mM, pH 7.5) buffer to give a 200 µM solution. Concentrations were determined by UV at 280 nm.
Production of NCoA-1 PAS B domain
NCOA-1 PAS B domain (residues 257-385 of human NCoA-1) was obtained at a concentration of 30 to 50 µM in HEPES (10 mM), NaCl (150 mM) and EDTA (3.4 mM) pH 7.4 according to the protocol reported by Seitz et al. [22] . For Nano-ESI experiments, the protein was dialyzed against an ammonium bicarbonate (50 mM, pH 7.5) buffer.
Mass spectrometry
Mass spectrometric analysis was performed with a hybrid quadrupole time-of-flight mass spectrometer (Q-Tof Ultima; Waters/Micromass Ltd, Manchester, UK) fitted with an automated chip-based nanoESI robot (NanoMate Model 100, Advion Bioscience, Ithaca, NY, USA). All measurements were performed in the positive ion mode. The cone voltage was kept at 45 V and the RF lens 1 at 100 V for all measurements. Argon was used as collision gas and a typical setting of 10 V was used for the collision energy parameter to optimize desolvation. The transmission of the ions through the quadrupole was optimized for the required mass range (m/z 1500-3000). Mass spectra were accumulated during 2-3 min to have a good signal-to-noise ratio. Calibration of the instrument was performed using 1 µM myoglobin solution in water/methanol/acetic acid (50/50/1, V/V).
Denaturing conditions were obtained by dissolving the sample in water/methanol/acetic acid (50/50/1, V/V), whereas non-denaturing conditions were obtained by using an ammonium bicarbonate (50 mM, pH 7.5) buffer.
NanoESI-MS Competition assay
Assays were carried out in a 96-well microtiter plate. In each well, the total volume was made up to 10 μL by the addition of ammonium bicarbonate buffer. The plate was incubated at room temperature for 5 min prior to the NanoESI-MS analysis. 
Results and discussion:
In a first approach, we planed to use a reference peptide with a known K D towards NCoA-1. 
Selection of peptidic reference ligands
The interaction between STAT6 and NCoA Figure 2B ) at a high concentration (60 μM, i.e. a 10-fold excess) compared to the protein concentration. Complexes (1:1 protein:ligand stoichiometry) were only observed for the charge states 7 and 8, whereas no complex was observed in the m/z 800-1700 range. This confirmed that charge states 6, 7 and 8 correspond to the folded active protein, whereas the higher charge states correspond to inactive conformations. In the case of peptide (1) (Figure 2A) , only a very weak signal at m/z~2800 was found for the 7 + complex that correspond to a 1:2 protein:ligand stoichiometry. Since we showed by isothermal titration calorimetry (ITC) that peptide (1) binds to NCoA-1 in a 1:1 interaction model [22] , we assumed that the 7 + complex only results from gas phase interactions due to the high concentration of the ligand.
This has been confirmed at lower peptide concentration (ratio 1:5 or below) by the disappearance of the signal corresponding to the 1:2 protein:ligand stoichiometry complex .
Specific versus nonspecific gas-phase interactions:
Recently µM and 12.1 µM, respectively, by a competitive fluorescence polarization assay [22] . Whatever the inhibitor chosen, at 6 μM protein and 60 μM cyclopeptide concentrations, complexes with 1:1, 1:2 or even 1:3 protein:ligand stoichiometry were observed for charge states 6, 7 and 8, as well for charge state 9, which was attributed to an unfolded protein complex (Figures 2C, 2D ). These peaks did not disappear at lower peptide concentration. We assumed that they result from nonspecific gasphase interactions, probably due to direct electrostatic interactions between deprotonated carboxylate groups from glutamate residues of the cyclopeptidic inhibitors and some protonated basic residues on the protein surface. Since electrostatic interactions are greatly enhanced in the gas phase compared to the solution phase (ratio of the dielectric constant of water compared to vacuum) [25] , nonspecific electrostatic adducts are stabilized. This assumption is first confirmed by the fact that the nonspecific adducts resulting from the aggregation of NCoA-1 with peptide (A) are stable even if a collision energy parameter of 80 V (max=120V) is applied. Secondly, the intensity ratio between the free protein and the aggregates is charge state dependent (Figure 2 C) : the higher the charge state, the higher the nonspecific adducts intensity. While fluorescence polarization competition assay showed that inhibitor (A) (K I = 3.0 µM) is a tighter binder than peptide (2) (K I = 7.5μM), we observed that peak intensities of [NCoA-1 : cyclopeptide (A)] complex are lower to those of [NCoA-1 : peptide (2)] complex (Figure 3) . Therefore, it is clear that without any quantification of the nonspecific gas-phase interactions, no direct results on the relative K D can be obtained.
In order to estimate the nonspecific binding, we first focused on the methodology developed by
Klassen et al. [16] , consisting on the analysis of noncovalent complexes, which result only from gas- complexes were observed for the highest charge state, i.e. 8 and 7, respectively. Moreover, the intensity ratio between the free and the bound fraction of protein was 10:1 for myoglobin but only 3.5:1 for lactalbumin. For lysozyme (MW~14300 Da), which has a molecular weight similar to that of lactalbumin but a completely different amino acid sequence, nonspecific complexes were observed for the charge states 8 and 7. For the charge state 8, we observed one or two molecules of (B) binding to the protein, whereas only a complex with a 1:1 stoichiometry was detected for the charge state 7. Thus, for all reference proteins, as well for NCoA-1, a charge state dependence of the peak intensities of the nonspecific complexes exists. Our observations suggest that the stability of the nonspecific complexes is related to the structure of the protein, which means that the main assumption of Klassen et al. is not valid. Klassen's method was developed and validated with protein:sugar complexes. Sugars are neutral components and the possible noncovalent interactions with a binding partner should only involve dipole interactions. However for cyclopeptide (B), we have strong evidence that electrostatic forces are involved in the nonspecific gas-phase interactions with proteins, which apparently creates quite a different situation.
Competition assay using myoglobin as internal standard:
To measure affinities of some noncovalent [NCoA-1 : cyclopeptide] complexes, even when ligands form nonspecific gas-phase interaction with the protein, we focused on a new competition assay consisting on the analysis of the peak intensity of the reference [NCoA-1 : peptide (2) Figure 6B) , the IC 50 values of peptide (6) was estimated to be 4 μM, corresponding to a K D of 17nM, which is again in good agreement with reported fluorescence polarization data (K D~4 0 nM) [22] . It must be noted that such low K D values that are lower than 2-3 orders of magnitude of the concentrations used in experiments, are usually difficult or impossible to measure by direct titration using nanoESI-MS [27].
Conclusion:
The potential of mass spectrometry for direct analysis of complex biological samples has been extensively demonstrated. Symbol ■ corresponds to the ligand. 
